Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02065648 · ClinicalTrials.gov registry record
Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet
A clinical trial of Vascular Disease, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02065648 is a study of Vascular Disease that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 20 participants, below the 802-participant average among 9 other Vascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02065648, a study of Vascular Disease, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE sequence is a viable alternative to contrast enhanced MRA in patients with renal insufficiency. There are no interventions--this is an observational study.
Conditions Studied
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02065648
The ClinicalTrials.gov registry entry for NCT02065648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 802-participant average among 9 other Vascular Disease trials with a reported enrollment target (98% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vascular Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02065648 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02065648 about?
NCT02065648 is a clinical study titled "Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet". The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE ...
What is the current status of trial NCT02065648?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-05. Estimated completion is 2015-03.
What conditions does trial NCT02065648 study?
This clinical trial studies the following conditions: Vascular Disease.
Who is sponsoring clinical trial NCT02065648?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02065648 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
RECRUITING
-
Use of Autologous Concentrated Bone Marrow Aspirate in Preventing Wound Complications in Below Knee Amputation (BKA)
COMPLETED · Phase 1
-
Study of Abnormal Blood Clotting in Children With Stroke
COMPLETED
-
Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)
COMPLETED · Phase 2
-
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.